As a critical inhibitor of angiogenesis, we hypothesized that the FKBPL-CD44 pathway has an important role in the pathogenesis of preeclampsia, which could be utilized for diagnostic and therapeutic purposes. The gene discussed is CD44; the disease is preeclampsia.